About Us
Contact Us
Regulatory
Community
Site Map
Links
Stock Price
Glossary
Investor Relations
Media Gateway
Businesses
Governance
Uranium 101
Careers
Company Profile Why Invest? Events Calendar Management Views Financial Reporting Shareholder Information
Q3
Q2
Down Arrow
Q1
Contact IR
 
TSX:  $15.46 (-1.76)
NYSE:  $11.81 (-1.80)
  15 minute delay
Uranium Price
Print Page
Print Page

Highlights

Cameco Corporation
Highlights
(Unaudited)

  Three Months Ended Six Months Ended  
  Jun 30/08 Jun 30/07 Jun 30/08 Jun 30/07  
   
Financial (in millions)  
  Revenue $620 $725 $1,213  $1,135   
  Earnings from operations 120 256 283  304   
  Net earnings 150 205 284  263   
  Adjusted net earnings (i) 142 203 293  270   
  Cash provided by operations 113 155 259  294   
  Working capital (end of period) 406  970   
  Net debt to capitalization 22% 10%  
   
Per common share  
  Net earnings - Basic $0.44 $0.58 $0.82  $0.75   
  - Diluted 0.42 0.55 0.79  0.71   
  - Diluted, adjusted (i) 0.39 0.54 0.81  0.73   
  Dividend 0.06 0.05 0.12  0.10   
   
  Weighted average number of paid common  
  shares outstanding (in thousands) 344,461 353,691 344,439  353,050   
   
Uranium price information  
    Average uranium spot price for the period (US$/lb) $61.33 $125.83 $67.42  $105.42 
    Average uranium realized price for the period (US$/lb) $47.35 $34.69 $43.84  $30.87 
    Average uranium realized price for the period (Cdn$/lb) $51.12 $40.11 $47.64  $36.10 
       
Sales volumes  
  Uranium (in thousands lbs U3O8) 6,348 11,232 13,794  17,507   
  Fuel services (tU) 3,078 3,773 6,471  6,163   
  Gold (troy ounces) 160,000 156,000 284,000  283,000   
  Electricity (TWh) 1.8 2.0 3.4  3.7   
   
Note: Currency amounts are expressed in Canadian dollars unless stated otherwise.  
   
   
(i) Net earnings for the six month period ended June 30, 2008, have been adjusted to exclude net recoveries of $28 million related to the restructuring of Centerra as well as charges of $21 million related to the mark-to-market of derivatives and $15 million related to stock compensation. Net earnings for the three month period ended June 30, 2008 have been adjusted to exclude net recoveries of $36 million related to the restructuring of Centerra and $3 million related to the mark-to-market of derivatives as well as a charge of $31 million related to stock compensation. Net earnings for the six month period ended June 30, 2007, have been adjusted to exclude a recovery of $8 million related to the mark-to-market of derivatives and a charge of $15 million related to stock compensation. Net earnings for the three month period ended June 30, 2007 have been adjusted to exclude a recovery of $9 million related to the mark-to-market of derivatives as well as a charge of $7 million related to stock compensation. Adjusted net earnings is a non-GAAP measure. Cameco believes the exclusion of these items provides a more meaningful basis for period-to-period comparisons of the company's financial results.